Pathogenic Mechanism of the FIG4 Mutation Responsible for Charcot-Marie-Tooth Disease CMT4J

English version České info

CMT4J is a severe form of Charcot-Marie-Tooth neuropathy caused by mutation of the phosphoinositide phosphatase FIG4/SAC3. Affected individuals are compound heterozygotes carrying the missense allele FIG4-I41T in combination with a null allele. Analysis using the yeast two-hybrid system demonstrated that the I41T mutation impairs interaction of FIG4 with the scaffold protein VAC14. The critical role of this interaction was confirmed by the demonstration of loss of FIG4 protein in VAC14 null mice. We developed a mouse model of CMT4J by expressing a Fig4-I41T cDNA transgene on the Fig4 null background. Expression of the mutant transcript at a level 5× higher than endogenous Fig4 completely rescued lethality, whereas 2× expression gave only partial rescue, providing a model of the human disease. The level of FIG4-I41T protein in transgenic tissues is only 2% of that predicted by the transcript level, as a consequence of the protein instability caused by impaired interaction of the mutant protein with VAC14. Analysis of patient fibroblasts demonstrated a comparably low level of mutant I41T protein. The abundance of FIG4-I41T protein in cultured cells is increased by treatment with the proteasome inhibitor MG-132. The data demonstrate that FIG4-I41T is a hypomorphic allele encoding a protein that is unstable in vivo. Expression of FIG4-I41T protein at 10% of normal level is sufficient for long-term survival, suggesting that patients with CMT4J could be treated by increased production or stabilization of the mutant protein. The transgenic model will be useful for testing in vivo interventions to increase the abundance of the mutant protein.

Vyšlo v časopise: Pathogenic Mechanism of the FIG4 Mutation Responsible for Charcot-Marie-Tooth Disease CMT4J. PLoS Genet 7(6): e32767. doi:10.1371/journal.pgen.1002104
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002104

Souhrn

Zdroje

1. ChowCYZhangYDowlingJJJinNAdamskaM 2007 Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 448 68 72

2. ZhangXChowCYSahenkZShyMEMeislerMH 2008 Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain 131 1990 2001

3. JinNChowCYLiuLZolovSNBronsonR 2008 VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P(2) in yeast and mouse. EMBO J 27 3221 3234

4. BotelhoRJEfeJATeisDEmrSD 2008 Assembly of a Fab1 phosphoinositide kinase signaling complex requires the Fig4 phosphoinositide phosphatase. Mol Biol Cell 19 4273 4286

5. SbrissaDIkonomovOCFennerHShishevaA 2008 ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and Sac3 in a complex to promote PIKfyve activity and functionality. J Mol Biol 384 766 779

6. DoveSKDongKKobayashiTWilliamsFKMichellRH 2009 Phosphatidylinositol 3,5-bisphosphate and Fab1p/PIKfyve underPPIn endo-lysosome function. Biochem J 419 1 13

7. ZhangYZolovSNChowCYSlutskySGRichardsonSC 2007 Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. Proc Natl Acad Sci U S A 104 17518 17523

8. SbrissaDIkonomovOCFuZIjuinTGruenbergJ 2007 Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. J Biol Chem 282 23878 23891

9. RudgeSAAndersonDMEmrSD 2004 Vacuole size control: regulation of PtdIns(3,5)P2 levels by the vacuole-associated Vac14-Fig4 complex, a PtdIns(3,5)P2-specific phosphatase. Mol Biol Cell 15 24 36

10. DuexJENauJJKauffmanEJWeismanLS 2006 Phosphoinositide 5-phosphatase Fig 4p is required for both acute rise and subsequent fall in stress-induced phosphatidylinositol 3,5-bisphosphate levels. Eukaryot Cell 5 723 731

11. FergusonCJLenkGMMeislerMH 2009 Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2. Hum Mol Genet 18 4868 4878

12. FergusonCJLenkGMMeislerMH 2009 PtdIns(3,5)P2 and autophagy in mouse models of neurodegeneration. Autophagy 6 170 171

13. ChowCYLandersJEBergrenSKSappPCGrantAE 2009 Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 84 85 88

14. IkonomovOCSbrissaDFliggerJDelvecchioKShishevaA 2010 ArPIKfyve regulates Sac3 protein abundance and turnover: disruption of the mechanism by Sac3I41T mutation causing Charcot-Marie-Tooth 4J disorder. J Biol Chem 285 26760 26764

15. NagaiTIbataKParkESKubotaMMikoshibaK 2002 A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20 87 90

16. GanesanAKHoHBodemannBPetersenSAruriJ 2008 Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. PLoS Genet 4 e1000298 doi:10.1371/journal.pgen.1000298

17. PeeblesCLFinkbeinerS 2007 RNA decay back in play. Nat Neurosci 10 1083 1084

18. ManfordAXiaTSaxenaAKStefanCHuF 2010 Crystal structure of the yeast Sac1: implications for its phosphoinositide phosphatase function. EMBO J 29 1489 1498

19. MuTWOngDSWangYJBalchWEYatesJR3rdSegatoriLKellyJW 2008 Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134 769 781

20. CvekBDvorakZ 2008 The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? Drug Discov Today 13 716 722

21. YuLMcPheeCKZhengLMardonesGARongY 2010 Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 465 942 946

22. DongXPShenDWangXDawsonTLiX 2010 PI(3,5)P2 Controls Membrane Traffic by Direct Activation of Mucolipin Ca2+ Release Channels in the Endolysosome. Nat Commun 1 Avialable: http://www.nature.com/ncomms/journal/v1/n4/full/ncomms1037.html. Accessed 30 November 2010

23. BuchnerDATrudeauMMeislerMH 2003 SCNM1, a putative RNA splicing factor that modifies disease severity in mice. Science 301 967 969

24. CushmanLJBurrowsHLSeasholtzAFLewandoskiMMuzyczkaN 2000 Cre-mediated recombination in the pituitary gland. Genesis 28 167 174

25. JamesPHalladayJCraigEA 1996 Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144 1425 1436

26. SullivanKAHayesJMWigginTDBackusCSu OhS 2007 Mouse models of diabetic neuropathy. Neurobiol Dis 28 276 285